/KASE, November 20, 2017/ – Chimpharm (Shymkent), whose shares are officially listed on Kazakhstan Stock Exchange (KASE), has notified KASE of a KZT35,519,246.41 loan received on November 16, 2017 (in Kazakh and Russian) – see more

[2017-11-20]